Qin C - Search Results

1

Genotoxicity assessments of N-nitrosoethylisopropylamine (NEIPA) and N-nitrosodiisopropylamine (NDIPA) in the C57BL/6J mouse.

Ye Q, Geng X, Jiang H, Qin C, Wu H, Wang S, Wen H. Ye Q, et al. Among authors: qin c. Mutat Res Genet Toxicol Environ Mutagen. 2024 May-Jun;896:503763. doi: 10.1016/j.mrgentox.2024.503763. Epub 2024 May 4. Mutat Res Genet Toxicol Environ Mutagen. 2024. PMID: 38821676

2

Effect of Pharmaceutical Excipients on Intestinal Absorption of Metformin via Organic Cation-Selective Transporters.

Ruan Y, Li X, You L, Chen J, Shen Y, Zhang J, Yuan Y, Kang L, Qin C, Wu C. Ruan Y, et al. Among authors: qin c. Mol Pharm. 2021 Jun 7;18(6):2198-2207. doi: 10.1021/acs.molpharmaceut.0c01104. Epub 2021 May 6. Mol Pharm. 2021. PMID: 33956455

3

Doxorubicin delivered by redox-responsive Hyaluronic Acid-Ibuprofen prodrug micelles for treatment of metastatic breast cancer.

Chai Z, Teng C, Yang L, Ren L, Yuan Z, Xu S, Cheng M, Wang Y, Yan Z, Qin C, Han X, Yin L. Chai Z, et al. Among authors: qin c. Carbohydr Polym. 2020 Oct 1;245:116527. doi: 10.1016/j.carbpol.2020.116527. Epub 2020 Jun 3. Carbohydr Polym. 2020. PMID: 32718631

4

Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes.

Qin C, He B, Dai W, Zhang H, Wang X, Wang J, Zhang X, Wang G, Yin L, Zhang Q. Qin C, et al. Mol Pharm. 2014 Oct 6;11(10):3233-41. doi: 10.1021/mp400691z. Epub 2014 Feb 28. Mol Pharm. 2014. PMID: 24559485

5

Bioresponsive nanocomplex integrating cancer-associated fibroblast deactivation and immunogenic chemotherapy for rebuilding immune-excluded tumors.

Liu L, Zhang B, Wu X, Cheng G, Han X, Xin X, Qin C, Yang L, Huo M, Yin L. Liu L, et al. Among authors: qin c. Nanomedicine. 2024 Jun;58:102743. doi: 10.1016/j.nano.2024.102743. Epub 2024 Mar 13. Nanomedicine. 2024. PMID: 38484918

6

ROS-scavenging nanomedicine for "multiple crosstalk" modulation in non-alcoholic fatty liver disease.

Xin X, Li J, Wu W, Zhao P, Yang Y, Zhu Y, Ren L, Qin C, Yin L. Xin X, et al. Among authors: qin c. Biomater Sci. 2023 May 16;11(10):3709-3725. doi: 10.1039/d2bm02161g. Biomater Sci. 2023. PMID: 37039546

7

CXCL10-coronated thermosensitive "stealth" liposomes for sequential chemoimmunotherapy in melanoma.

Xin X, Zhou Y, Li J, Zhang K, Qin C, Yin L. Xin X, et al. Among authors: qin c. Nanomedicine. 2023 Feb;48:102634. doi: 10.1016/j.nano.2022.102634. Epub 2022 Nov 30. Nanomedicine. 2023. PMID: 36462759

8

Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.

Lv Y, Xu C, Zhao X, Lin C, Yang X, Xin X, Zhang L, Qin C, Han X, Yang L, He W, Yin L. Lv Y, et al. Among authors: qin c. ACS Nano. 2018 Feb 27;12(2):1519-1536. doi: 10.1021/acsnano.7b08051. Epub 2018 Jan 24. ACS Nano. 2018. PMID: 29350904

9

Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation.

Qin C, Wu M, Xu S, Wang X, Shi W, Dong Y, Yang L, He W, Han X, Yin L. Qin C, et al. Int J Pharm. 2018 Jul 10;545(1-2):37-44. doi: 10.1016/j.ijpharm.2018.04.011. Epub 2018 Apr 9. Int J Pharm. 2018. PMID: 29649518

10

Desirable PEGylation for improving tumor selectivity of hyaluronic acid-based nanoparticles via low hepatic captured, long circulation times and CD44 receptor-mediated tumor targeting.

Teng C, Chai Z, Yuan Z, Ren L, Lin C, Yan Z, He W, Qin C, Yang L, Han X, Yin L. Teng C, et al. Among authors: qin c. Nanomedicine. 2020 Feb;24:102105. doi: 10.1016/j.nano.2019.102105. Epub 2019 Nov 15. Nanomedicine. 2020. PMID: 31740406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,018 results

Search Page

Filters